Paclitaxel Injection

Paclitaxel Injection

Categories : Oncology

Product Packaging : Single Vial

Product Composition : 30mg/5ml, 100mg/16.7ml, 150mg/25ml, 260mg/43.4ml, 300mg/50ml

Send Message

Paclitaxel Injection is an antineoplastic medication widely used in the treatment of various solid tumors, including breast cancer, ovarian cancer, and lung cancer. The medicine works by stabilizing microtubules within cancer cells, preventing normal cell division and leading to inhibition of tumor growth. Genliva Wellness LLP is a trusted Paclitaxel Injection Manufacturer in India offering high-quality oncology formulations for domestic and international pharmaceutical markets.

This injectable formulation is commonly prescribed as part of chemotherapy regimens for several advanced and metastatic cancers. As a reliable Paclitaxel Injection Exporter from India, Genliva Wellness LLP supplies quality-assured oncology products to healthcare institutions and pharmaceutical distributors worldwide.

Paclitaxel is one of the most widely utilized chemotherapy agents in oncology and plays an important role in the management of a broad range of malignancies.

Paclitaxel Injection is formulated to provide effective antitumor activity against multiple types of cancers.

  • Contains Paclitaxel as the active ingredient
  • Taxane-based anticancer agent
  • Stabilizes microtubules in cancer cells
  • Inhibits cell division and tumor growth
  • Broad-spectrum antineoplastic activity
  • Intravenous injectable formulation

Paclitaxel Injection is used in the treatment and management of various malignant conditions.

  • Breast cancer
  • Ovarian cancer
  • Non-small cell lung cancer
  • Cervical cancer
  • Kaposi's sarcoma
  • Advanced solid tumors

Paclitaxel Injection offers proven anticancer efficacy across a wide range of oncology indications.

  • Helps prevent cancer cell multiplication
  • Effective against multiple solid tumors
  • Supports comprehensive cancer treatment strategies
  • Assists in controlling tumor progression
  • Targets rapidly dividing malignant cells
  • Contributes to improved treatment outcomes

whatsapp-app